ABCA3 and interstitial lung disease: Heterozygous SFTPC mutations concomitant, as well as heterozygous mutations in ATP-binding cassette transporter A3 (ABCA3) in infants with interstitial lung diseases (ILD), might likely led to development of clinical ILD [35].